Literature DB >> 24846234

Obesity and coronary microvascular disease - implications for adipose tissue-mediated remote inflammatory response.

Zsolt Bagi, Zuzana Broskova, Attila Feher1.   

Abstract

It is believed that obesity has detrimental effects on the coronary circulation. These include immediate changes in coronary arterial vasomotor responsiveness and the development of occlusive large coronary artery disease. Despite its critical role in regulating myocardial perfusion, the altered behavior of coronary resistance arteries, which gives rise to coronary microvascular disease (CMD) is poorly understood in obesity. A chronic, low-grade vascular inflammation has been long considered as one of the main underlying pathology behind CMD. The expanded adipose tissue and the infiltrating macrophages are the major sources of pro-inflammatory mediators that have been implicated in causing inadequate myocardial perfusion and, in a long term, development of heart failure in obese patients. Much less is known the mechanisms regulating the release of these cytokines into the circulation that enable them to exert their remote effects in the coronary microcirculation. This mini review aims to examine recent studies describing alterations in the vasomotor function of coronary resistance arteries and the role of adipose tissue-derived pro-inflammatory cytokines and adipokines in contributing to CMD in obesity. We provide examples of regulatory mechanisms by which adipokines are released from adipose tissue to exert their remote inflammatory effects on coronary microvessels. We identify some of the important challenges and opportunities going forward.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24846234      PMCID: PMC4167722          DOI: 10.2174/1570161112666140423221843

Source DB:  PubMed          Journal:  Curr Vasc Pharmacol        ISSN: 1570-1611            Impact factor:   2.719


  127 in total

1.  Differences in circulating concentrations of total, free and bound leptin relate to gender and body composition in adult humans.

Authors:  M G McConway; D Johnson; A Kelly; D Griffin; J Smith; A M Wallace
Journal:  Ann Clin Biochem       Date:  2000-09       Impact factor: 2.057

2.  Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial.

Authors:  Katherine Esposito; Alessandro Pontillo; Carmen Di Palo; Giovanni Giugliano; Mariangela Masella; Raffaele Marfella; Dario Giugliano
Journal:  JAMA       Date:  2003-04-09       Impact factor: 56.272

3.  Coronary and aortic endothelial function affected by feedback between adiponectin and tumor necrosis factor α in type 2 diabetic mice.

Authors:  Hanrui Zhang; Yoonjung Park; Cuihua Zhang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-09-02       Impact factor: 8.311

4.  Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes.

Authors:  J C Pickup; G D Chusney; S M Thomas; D Burt
Journal:  Life Sci       Date:  2000-06-08       Impact factor: 5.037

5.  TNF-alpha dilates cerebral arteries via NAD(P)H oxidase-dependent Ca2+ spark activation.

Authors:  Sergey Y Cheranov; Jonathan H Jaggar
Journal:  Am J Physiol Cell Physiol       Date:  2005-11-02       Impact factor: 4.249

6.  Relation between plasma tumor necrosis factor-alpha and insulin sensitivity in elderly men with non-insulin-dependent diabetes mellitus.

Authors:  J Nilsson; S Jovinge; A Niemann; R Reneland; H Lithell
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-08       Impact factor: 8.311

7.  Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss.

Authors:  P Dandona; R Weinstock; K Thusu; E Abdel-Rahman; A Aljada; T Wadden
Journal:  J Clin Endocrinol Metab       Date:  1998-08       Impact factor: 5.958

8.  Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis.

Authors:  David Hürlimann; Adrian Forster; Georg Noll; Frank Enseleit; Rémy Chenevard; Oliver Distler; Markus Béchir; Lukas E Spieker; Michel Neidhart; Beat A Michel; Renate E Gay; Thomas F Lüscher; Steffen Gay; Frank Ruschitzka
Journal:  Circulation       Date:  2002-10-22       Impact factor: 29.690

9.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.

Authors:  G S Hotamisligil; N S Shargill; B M Spiegelman
Journal:  Science       Date:  1993-01-01       Impact factor: 47.728

10.  Tumor necrosis factor-alpha antagonism improves vasodilation during hyperinsulinemia in metabolic syndrome.

Authors:  Manfredi Tesauro; Francesca Schinzari; Valentina Rovella; Domenico Melina; Nadia Mores; Angela Barini; Marco Mettimano; Davide Lauro; Micaela Iantorno; Michael J Quon; Carmine Cardillo
Journal:  Diabetes Care       Date:  2008-04-04       Impact factor: 19.112

View more
  14 in total

1.  Augmented oxidative stress and preserved vasoconstriction induced by hydrogen peroxide in coronary arteries in obesity: role of COX-2.

Authors:  Elvira Santiago; Maria Pilar Martínez; Belén Climent; Mercedes Muñoz; Ana María Briones; Mercedes Salaices; Albino García-Sacristán; Luis Rivera; Dolores Prieto
Journal:  Br J Pharmacol       Date:  2016-10-07       Impact factor: 8.739

Review 2.  Mechanisms and clinical implications of endothelium-dependent vasomotor dysfunction in coronary microvasculature.

Authors:  Sharif A Sabe; Jun Feng; Frank W Sellke; M Ruhul Abid
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-03-25       Impact factor: 5.125

Review 3.  Role of peripheral vascular resistance for the association between major depression and cardiovascular disease.

Authors:  Elena V Bouzinova; Ove Wiborg; Christian Aalkjaer; Vladimir V Matchkov
Journal:  J Cardiovasc Pharmacol       Date:  2015-04       Impact factor: 3.105

4.  The Associations between Various Ectopic Visceral Adiposity and Body Surface Electrocardiographic Alterations: Potential Differences between Local and Remote Systemic Effects.

Authors:  Po-Ching Chi; Shun-Chuan Chang; Chun-Ho Yun; Jen-Yuan Kuo; Chung-Lieh Hung; Charles Jia-Yin Hou; Chia-Yuan Liu; Fei-Shih Yang; Tung-Hsin Wu; Hiram G Bezerra; Hung-I Yeh
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

5.  Associations between CT-determined visceral fat burden, hepatic steatosis, circulating white blood cell counts and neutrophil-to-lymphocyte ratio.

Authors:  Kuo-Tzu Sung; Richard Kuo; Jing-Yi Sun; Ta-Chuan Hung; Shun-Chuan Chang; Chuan-Chuan Liu; Chun-Ho Yun; Tung-Hsin Wu; Chung-Lieh Hung; Hung-I Yeh; Charles Jia-Yin Hou; Ricardo C Cury; David A Zidar; Hiram G Bezerra; Chris T Longenecker
Journal:  PLoS One       Date:  2018-11-20       Impact factor: 3.240

6.  The impact of cardiovascular risk factors on cognition in Hispanics and non-Hispanic whites.

Authors:  Ariana Stickel; Andrew McKinnon; John Ruiz; Matthew D Grilli; Lee Ryan
Journal:  Learn Mem       Date:  2019-06-17       Impact factor: 2.460

Review 7.  Obesity Related Coronary Microvascular Dysfunction: From Basic to Clinical Practice.

Authors:  K Selthofer-Relatić; I Bošnjak; A Kibel
Journal:  Cardiol Res Pract       Date:  2016-03-22       Impact factor: 1.866

8.  Overweight status is associated with extensive signs of microvascular dysfunction and cardiovascular risk.

Authors:  Sunni R Patel; Srikanth Bellary; Said Karimzad; Doina Gherghel
Journal:  Sci Rep       Date:  2016-08-31       Impact factor: 4.379

Review 9.  Targeting Obesity and Diabetes to Treat Heart Failure with Preserved Ejection Fraction.

Authors:  Raffaele Altara; Mauro Giordano; Einar S Nordén; Alessandro Cataliotti; Mazen Kurdi; Saeed N Bajestani; George W Booz
Journal:  Front Endocrinol (Lausanne)       Date:  2017-07-17       Impact factor: 5.555

10.  Liraglutide treatment improves the coronary microcirculation in insulin resistant Zucker obese rats on a high salt diet.

Authors:  Vijayakumar Sukumaran; Hirotsugu Tsuchimochi; Takashi Sonobe; Mark T Waddingham; Mikiyasu Shirai; James T Pearson
Journal:  Cardiovasc Diabetol       Date:  2020-02-24       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.